RC301

N/A

Report date: 2022/11/04 13:51:01

Base Information

Drug NameRC301

Drug Alias NameRC301

ClassificationBiologics > Protein drugs > ImmunoglobulinBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody fragment > Single-domain antibody (Nanobody)

Mechanisms of ActionUpdating

TargetsUpdating

Therapy Area/IndicationsN/A

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaPreclinical

Originator CompaniesRuishengke Biopharmaceutical (Shanghai) Co Ltd

China Registration ClassN/A

Develop Information

Active CompaniesRuishengke Biopharmaceutical (Shanghai) Co Ltd

Inactive CompaniesN/A

Active IndicationsN/A

Inactive IndicationsN/A

Other Information

ATC CodeN/A